Vertaling van "income level " (Frans → Nederlands) :

variable, the BIM u (increased reimbursement, mostly corresponding to people with a low income level) and BO (normal reimbursement). Measurement of inequalities
BIM: Bénéficiaire à Intervention Majorée (beneficiary of increased reimbursement); BO: Bénéficiaire Ordinaire

8.2.2.2 Inequalities in the indicators of accessibility The percentage of households reporting to have delayed contacts with the health system for financial reasons was strongly related to the income level, with 27% of delay in the households of the lowest quintile versus 4%
114 These data are not presented in detail in this report. 8.2.2.2 Inequalities in the indicators of accessibility The percentage of households reporting to have delayed contacts with the health system for financial reasons was strongly related to the income level, with 27% of delay in the households of the lowest quintile versus 4%

The social groups can be defined by different characteristics at household, individual or even geographical levels: the household income, the educational level, the occupation, a deprivation index, or a combination of some of those variables.
one or more synthetic inequality measures in the health-related indicator(s). Characteristics used to define the social groups The social groups can be defined by different characteristics at household, individual or even geographical levels: the household income, the educational level, the occupation, a deprivation index, or a combination of some of those variables.

31-oct.-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » En savoir plus
31-okt-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » meer